Effects of Β2/aβ2 on Oxldl-Induced CD36 Activation in THP-1 Macrophages
Chao He,Guiting Zhang,Hang Ouyang,Peng Zhang,Yudan Chen,Ren Wang,Hong Zhou
DOI: https://doi.org/10.1016/j.lfs.2019.117000
IF: 6.78
2019-01-01
Life Sciences
Abstract:Aims: beta 2-glycoprotein I/anti-beta 2-glycoprotein I antibody complex (beta 2/a beta 2) could promote oxLDL-induced endothelial inflammation through Toll-like receptor 4 (TLR4), therefore accelerates atherosclerosis in patients with anti-phospholipid syndrome (APS). However, effects of beta 2/a beta 2 and TLR4 on oxLDL-induced CD36 activation in macrophages remain to be elucidated and are currently under investigation. Materials and methods: THP-1 macrophages with or without the pre-treatment of TAK-242, a TLR4 inhibitor, were treated with RPMI 1640, oxLDL, oxLDL+beta 2/a beta 2 or oxLDL + LPS.CD36 expression and subsequent intracellular lipid accumulation, cholesterol-transportation-related proteins (ACAT1, ABCG1 and ABCA1) expression, inflammatory cytokines (IL-1 beta, TNF-alpha and IL-6) secretion, focal adhesion kinases (FAK) activation and matrix metalloproteinases (MMP-2 and MMP-9) expression by these THP-1 macrophages were evaluated. Moreover, effects of TLR4 on oxLDL+beta 2/a beta 2-induced peroxisome proliferators-activated receptor-gamma (PPAR-gamma) expression and CD36 translocation have also been observed. Key findings: Compared with oxLDL-treated ones, CD36 expression, intracellular lipid accumulation and FAK activation were inhibited, whereas the levels of inflammatory cytokines and MMPs were upregulated in THP-1 macrophages treated with oxLDL+beta 2/a beta 2 (p < 0.05). Moreover, observed differences between oxLDL-treated and oxLDL+beta 2/a beta 2-treated THP-1 macrophages could be reversed by TAK-242 pre-treatment (p < 0.05). Furthermore, oxLDL+beta 2/a beta 2 promoted PPAR-gamma expression and CD36 cytoplasmic translocation in THP-1 macrophages, these effects could also be attenuated by TAK-242 (p < 0.05). Significance: Through a TLR4 dependent manner, beta 2/a beta 2 inhibited oxLDL-induced CD36 expression, lipid accumulation and FAK activation, while promoted inflammatory cytokines and MMPs expression in THP-1 macrophages, indicating the novel dual roles played by beta 2/a beta 2 in APS-related atherosclerosis.